Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt · Delayed Price · Currency is EGP 298.24
-4.06 (-1.34%)
At close: Oct 22, 2026
EGX:MPCI Financials Overview
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 1,706 | 1,706 | 1,508 | 871.91 | 663.83 | 551.26 |
Revenue Growth | 13.14% | 13.14% | 72.93% | 31.34% | 20.42% | 6.40% |
Gross Profit Gross Profit Growth | 682.18 | 682.18 | 683.78 | 300.29 | 212.95 | 149.39 |
Operating Income Operating Income Growth | 523.43 | 523.43 | 542.53 | 211.41 | 95.89 | 69.04 |
Net Income Net Income Growth | 479.96 | 479.96 | 505.28 | 191.46 | 90.44 | 74.09 |
Earnings Per Share EPS Growth | 21.10 | 21.10 | 22.20 | 34.04 | 16.08 | 13.17 |
EPS Growth | -4.96% | -4.96% | -34.78% | 111.70% | 22.07% | - |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 611.39 | 611.39 | 678.63 | 519.86 | 143.53 | 83.83 |
Total Debt Total Debt Growth | 73.03 | 73.03 | 94.94 | 177.04 | 13.32 | 4.73 |
Net Cash (Debt) Net Cash Growth | 538.36 | 538.36 | 583.69 | 342.81 | 130.21 | 79.1 |
Net Cash Growth | -7.77% | -7.77% | 70.27% | 163.29% | 64.62% | 67.45% |
Net Cash Per Share Net Cash Per Share Growth | 23.67 | 23.67 | 25.65 | 60.94 | 23.15 | 14.06 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 220.28 | 220.28 | 86.89 | 183.2 | 57.94 | 36.47 |
Capital Expenditures CapEx Growth | -34.89 | -34.89 | -21.23 | -24.37 | -11.45 | -12.92 |
Free Cash Flow Free Cash Flow Growth | 185.39 | 185.39 | 65.65 | 158.83 | 46.49 | 23.55 |
Free Cash Flow Growth | 182.38% | 182.38% | -58.66% | 241.64% | 97.45% | 1578.00% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 39.99% | 39.99% | 45.35% | 34.44% | 32.08% | 27.10% |
Operating Margin | 30.68% | 30.68% | 35.98% | 24.25% | 14.45% | 12.52% |
Pretax Margin | 35.22% | 35.22% | 43.26% | 26.32% | 16.57% | 14.21% |
Profit Margin | 28.13% | 28.13% | 33.51% | 21.96% | 13.62% | 13.44% |
FCF Margin | 10.87% | 10.87% | 4.35% | 18.22% | 7.00% | 4.27% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Dividend Per Share Dividend Per Share Growth | 13.187 | 13.187 | 13.187 | 4.000 | 2.000 |
Dividend Per Share Growth | 229.68% | 0% | 229.67% | 100.00% | - |
Dividend Yield | 4.42% | 5.54% | 17.81% | 4.45% | 6.46% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.13 | 11.29 | 3.33 | 2.64 | 1.93 | 1.05 |
P/FCF Ratio | 36.60 | 29.23 | 25.65 | 3.18 | 3.75 | 3.31 |
PS Ratio | 3.98 | 3.18 | 1.12 | 0.58 | 0.26 | 0.14 |